Last reviewed 2026-04-20 · How we verify

Torasemide

At a glance

Approved indications

• Decompensated cardiac failure
• Edema
• Edema due to Hepatic Cirrhosis
• Hypertensive disorder
• Peripheral Edema due to Chronic Heart Failure
• Pulmonary Edema due to Chronic Heart Failure
• Renal Disease with Edema

Common side effects

No common side effects on file.

Key clinical trials

• Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder (PHASE2)
• Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure (PHASE4)
• Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone (PHASE3)
• A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease (PHASE3)
• Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects (PHASE3)
• A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects (PHASE3)
• A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions: (PHASE1)
• A Study of Ultra High Dose Diuretics to Treat Heart Failure (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.